Paxman AB (publ) ( PXMBF) - Key Metrics
PXMBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $4.47 | $0.11 | -$0.14 | -$0.35 |
| 2026Q1 | $3.83 | -$0.01 | -$0.10 | -$0.27 |
| 2025Q4 | $3.62 | -$0.38 | $0.24 | $0.02 |
| 2025Q3 | $3.92 | $0.06 | -$0.27 | -$0.46 |
| 2025Q2 | $3.37 | -$0.14 | $0.02 | -$0.20 |
PXMBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 77.08 |
| 2026Q1 | 0% | -1531.12 |
| 2025Q4 | 0% | -21.23 |
| 2025Q3 | 0% | 143.81 |
| 2025Q2 | 0% | -58.97 |
PXMBF
Price: $3.50
52 week price:
Earnings Per Share: 0.12 USD
P/E Ratio: 29.17
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 81.5 million